Feedback / Questions
AU-007 - Aulos Biosci
https://www.businesswire.com/news/home/20221110005216/en/Aulos-Bioscience-Presents-Initial-Data-From-First-in-Human-Phase-12-Clinical-Trial-of-Computationally-Designed-Antibody-AU-007-at-37th-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting
Nov 10, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next